Related Experiment Video
Updated: Aug 14, 2026

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
Published on: August 18, 2016
Assessment of myocardial sympathetic activity in coronary heart disease
Insights
In patients with coronary artery disease, pacing increased adrenaline and noradrenaline levels. The heart extracts adrenaline and releases noradrenaline, with these changes unaffected by pacing or propranolol.
Area of Science:
- Cardiology
- Neuroendocrinology
- Biochemistry
Background:
- Coronary artery disease (CAD) impacts cardiac function and neurohormonal regulation.
- Understanding catecholamine dynamics in the heart is crucial for managing CAD.
- Adrenaline, noradrenaline, and dopamine beta-hydroxylase play key roles in cardiovascular stress responses.
Purpose of the Study:
- To investigate the release and extraction of catecholamines (adrenaline and noradrenaline) by the heart in patients with CAD.
- To determine the effect of pacing-induced ischemia on cardiac catecholamine metabolism.
- To assess the influence of propranolol on these neurohormonal responses during ischemia.
Main Methods:
- Measurement of adrenaline, noradrenaline, and dopamine beta-hydroxylase concentrations in arterial and coronary sinus blood.
- Analysis of blood samples at rest and during pacing-induced ischemia in 14 CAD patients.
- Administration of propranolol to evaluate its effect on catecholamine levels and cardiac release/extraction.
Main Results:
- Pacing significantly increased arterial and coronary sinus concentrations of adrenaline and noradrenaline.
- The heart demonstrated extraction of adrenaline and release of noradrenaline, independent of pacing.
- Propranolol did not alter these arteriovenous differences during pacing-induced ischemia.
- Dopamine beta-hydroxylase levels showed no significant change, except for a release from the heart during pacing after propranolol administration.
Conclusions:
- Cardiac sympathetic activity and circulating catecholamines are elevated during ischemia in CAD patients.
- The heart acts as a site for adrenaline extraction and noradrenaline release, a function largely preserved during pacing-induced ischemia.
- Propranolol's effects on cardiac catecholamine handling in this context require further investigation.
Abstract:
We measured adrenaline, noradrenaline and dopamine beta-hydroxylase in arterial and in coronary sinus blood in 14 patients with coronary artery disease, at rest and under pacing-induced ischemia. Pacing increased the concentrations of adrenaline and noradrenaline in both arterial and coronary sinus blood. The origin of the adrenaline increase appears to be extramyocardial. The arteriovenous differences indicated that the heart extracts adrenaline and releases noradrenaline. These differences were not significantly changed by pacing, nor by the administration of propranolol. No marked changes in the concentrations of dopamine beta-hydroxylase were observed, except under pacing after propranolol, in which case a release from the heart occurred.
Related Concept Videos
Pathophysiology of Cardiac Performance
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome V: Nursing Management
Angina III: Clinical Manifestations and Assessment

